Keshav Kumar

Hi. Thanks for the opportunity. So a peer of ours has been very bullish about late stage opportunities coming to Indian CDMOs due to China Plus One and all that. So as per our strategy and with whatever opportunities we are seeing, what is your view on whether we should see a better late stage accretion to the pipeline going forward than we have seen in the past, like we have onboarded a Phase-3 molecule this…